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Abstract
We perform differential expression analysis of high-throughput sequencing count
data under a Bayesian nonparametric framework, removing sophisticated ad-hoc
pre-processing steps commonly required in existing algorithms. We propose to use
the gamma (beta) negative binomial process, which takes into account different
sequencing depths using sample-specific negative binomial probability (dispersion)
parameters, to detect differentially expressed genes by comparing the posterior
distributions of gene-specific negative binomial dispersion (probability) parameters.
These model parameters are inferred by borrowing statistical strength across both
the genes and samples. Extensive experiments on both simulated and real-world
RNA sequencing count data show that the proposed differential expression analysis
algorithms clearly outperform previously proposed ones in terms of the areas under
both the receiver operating characteristic and precision-recall curves.
Keywords: Markov chain Monte Carlo, negative binomial processes, over-dispersion,
RNA-Seq, symmetric Kullback-Leibler divergence
∗ Department of Electrical & Computer Engineering, Center for Bioinformatics & Genomic Systems
Engineering, Texas A&M University, College Station, TX 77843, USA.
† Department of Information, Risk, & Operations Management and Department of Statistics and Data
Sciences, The University of Texas at Austin, Austin, TX 78712, USA.
# Correspondence should be addressed to Xiaoning Qian (xqian@ece.tamu.edu) or Mingyuan Zhou
(mingyuan.zhou@mccombs.utexas.edu).
1
ar
X
iv
:1
60
8.
03
99
1v
2 
 [s
tat
.A
P]
  2
 M
ay
 20
17
1 Introduction
There has been significant recent interest in analyzing RNA sequencing (RNA-Seq) count
data for studying life systems [Wang et al., 2009, Metzker, 2010]. It is challenging to model
RNA-Seq data, not only because it is typically a large-p-small-n problem [West, 2003]
where the data dimension is high while the sample size is small, but also because the
sequencing counts are nonnegative, skewed, having large dynamical ranges, and highly
over-dispersed [Anders and Huber, 2010, Datta and Nettleton, 2014]. A key task in RNA-
Seq analysis is to identify the genes that are differentially expressed between different
groups of samples (e.g., samples measured under different medical conditions) [Wang
et al., 2010, Robinson and Oshlack, 2010, Anders and Huber, 2010, Oshlack et al., 2010,
Li et al., 2011, Li and Tibshirani, 2013]. The expression level of each RNA locus, here
the gene, is determined by the number of sequenced reads to the transcript [Mortazavi
et al., 2008]. Unlike a gene probe based method such as microarrays [Schena et al., 1995],
the abundance of genes in RNA-Seq is restricted by the sequencing depth and there often
exist dependencies between the expressions of different transcripts [Roberts et al., 2011].
Modeling the sequencing counts using an over-dispersed count distribution, such as
the negative binomial (NB) distribution [Greenwood and Yule, 1920, Bliss and Fisher,
1953], is one of the most popular approaches for differential expression analysis [Robinson
et al., 2010, Anders and Huber, 2010]. In the null hypothesis that a gene is not differently
expressed, it is common to assume that the expectations of the counts of that gene are the
same across different groups, after making adjustments to account for both technical and
biological variations. In particular, almost all existing comparative analysis algorithms,
before downstream analyses, require normalizing the sequencing counts to compensate the
variations of sequencing depths across samples [Soneson and Delorenzi, 2013, Dillies et al.,
2013, Zyprych-Walczak et al., 2015]. For instance, edgeR and DESeq, two widely used
differential expression analysis R software packages adopt different ad-hoc normalization
procedures: edgeR either calculates a trimmed mean of M-values [Robinson and Oshlack,
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2010] between each pair of samples or uses an upper quantile of samples [Bullard et al.,
2010] for normalization [Robinson et al., 2010], while DESeq takes the median of the
ratios of observed sample’s counts to the geometric mean across samples as a scaling
factor for that specific sample [Anders and Huber, 2010, Love et al., 2014].
Normalizing the sequencing counts, however, inevitably destroys the discrete nature
of the raw data and makes the performance clearly depend on whether the introduced
normalization is suitable for the structure of the RNA-Seq data under study [Soneson and
Delorenzi, 2013, Dillies et al., 2013, Zyprych-Walczak et al., 2015]. If the normalization
procedure extracts normalization constants from the data under study to parameterize
the distributions of the gene counts, the discrete nature of the raw data is preserved, but
the model can no longer be considered as a generative model. In addition, almost all
existing normalization procedures assume that most of the genes are not differentially
expressed, and the differentially expressed genes are equally likely to be up- and down-
regulated [Love´n et al., 2012, Lorenz et al., 2014, Risso et al., 2014a,b]. The violation of
the assumption may potentially be addressed by using external RNA control consortium
(ERCC) spike-in sequences for controls; however, it is shown in Risso et al. [2014a,b] that
the read counts for ERCC spike-ins alone are usually not stable enough to be used for
normalization. Moreover, despite that a wide array of methods have been proposed to
adjust the counts to account for technical and biological variations, there is not a single
one that clearly outperforms the others under various scenarios [Soneson and Delorenzi,
2013, Rapaport et al., 2013, Dillies et al., 2013, Risso et al., 2014a, Zyprych-Walczak
et al., 2015, Zhang et al., 2014].
In this paper, rather than heuristically modifying the data and estimating the model
parameters based on an empirical Bayes procedure, we introduce a generative model to
analyze differential expression directly on the raw sequencing counts, without the need
to preprocess the data by normalization. Instead of using parametric count distributions
to describe the counts, we use a stochastic process to model the observed sample-gene
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random count matrix in each group, whose model parameters are estimated by sharing
statistical strength across both the genes and samples. The stochastic process can be
used to explain not only the counts and the total number of expressed genes in the
observed random count matrix, but also the number of newly expressed genes and the
counts on both existing and newly expressed genes to be brought by a new sample.
Such flexible random-process-based models lift the need of ad-hoc data normalization and
strict parametric assumptions, allowing heterogeneity across samples and gene expression
variations across different conditions to be well captured.
More specifically, moving beyond existing algorithms that model over-dispersed counts
with the NB distribution, our Bayesian nonparametric (BNP) algorithms model the gene
counts using the gamma-negative binomial process (GNBP) [Zhou et al., 2016], which
mixes the NB shape parameter for each gene with the distribution of the weight of an atom
of a gamma process [Ferguson, 1973], or beta-negative binomial process (BNBP) [Zhou
et al., 2012, Zhou and Carin, 2015, Broderick et al., 2015], which mixes the NB probability
parameter of each gene with the distribution of the weight of an atom of a beta process
[Hjort, 1990]. In addition to the GNBP and BNBP, for comparison, we have extended the
negative binomial process (NBP) of Zhou et al. [2016] by multiplying the gene-specific
Poisson rates with gamma distributed sample-specific scaling parameters, and refer to it
as the scaled NBP. While the NBP of Zhou et al. [2016] is not expected to work well since
it does not explicitly model the variation of a sample’s total count, the scaled NBP, even
with a scaling parameter for each sample to capture that variation, is found to provide
poor performance, indicating a clear limitation of the Poisson distribution assumption.
We will show that while the variations of the gene counts across samples are well captured
by neither the Poisson rates of the scaled NBP nor the normalized Poisson rates of the
NBP, they are well modeled by both the GNBP and BNBP, using the NB shape and
probability parameters, respectively.
Unlike previous algorithms for differential expression analysis, the proposed BNP
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algorithms require no normalization pre-processing steps and they infer the posterior
distributions, instead of point estimates, of their model parameters, using Gibbs sampling
with closed-form update equations, achieving state-of-the-art performance in detecting
truly differentially expressed genes for both synthetic and real data. To our knowledge,
we are the first in constructing BNP algorithms with these distinct advantages to analyze
the sequencing counts to detect differential expression in genomics.
The remainder of the paper is organized as follows. After reviewing existing differen-
tial expression analysis algorithms in Section 2, we introduce the NBP-Seq, GNBP-Seq,
and BNBP-Seq for differential expression analysis in Section 3. We present experimen-
tal results on both synthetic and real-world benchmark RNA-Seq data in Section 4 and
show that both the proposed GNBP-Seq and BNBP-Seq clearly outperform previously
proposed differential express analysis algorithms. We conclude the paper in Section 5.
2 Differential expression analysis
For J RNA-Seq samples organized into the same group, let us denote njk as the number
of reads in sequencing sample j ∈ {1, . . . , J} that are assigned to gene k ∈ {1, . . . , K},
where K is the number of genes in the genome. Since the counts of a gene across samples
are often over-dispersed, it is natural to model them using a NB distribution, where its
variance σ2 is related to its mean µ as σ2 = µ+φµ2, where φ is the dispersion parameter.
As it is also common to refer to r = φ−1 as the dispersion parameter, to avoid ambiguity,
we will refer to r = φ−1 as the NB shape parameter.
Methods such as edgeR and DESeq propose different ways to estimate φ. EdgeR
models the gene count njk as a NB distribution with mean njλjk and dispersion φk,
where nj is the observed total count (or the sum of adjusted counts) for sample j, λjk
represents the abundance of gene k in sample j, and φk is considered as the coefficient
of biological variation that is estimated by conditional maximum likelihood [Smyth and
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Verbyla, 1996]. Furthermore, an empirical Bayes procedure is applied to shrink the
dispersion parameters φk towards a common value [Robinson and Smyth, 2007].
DESeq also models the gene counts with the NB distribution. It considers two terms
to estimate the variance σ2jk for gene k in sample j, where the first term (shot noise)
is associated with the mean expression of the gene, and the second one (raw variance)
takes into account the biological variations between replicates. More specifically, it lets
σ2jk = µjk + n
2
jvk,ρ(j). Here, ρ(j) is the group to which sample j belongs, and vk,ρ(j) is the
per-gene raw variance, which is a smooth function of λ and ρ, an assumption that allows
pooling data from different genes to estimate their variances.
Another widely used tool, baySeq [Hardcastle and Kelly, 2010], takes an empirical
Bayesian approach to estimate the posterior probabilities of a set of models that define
different patterns of differential expression for each gene. For instance, in the simplest
case of a pairwise comparison between conditions A and B, with two biological replicates
for each condition, the model for no differential expression is defined by the set of samples
{A1, A2, B1, B2}, while differential expression between conditions A and B is defined by
the sets {A1, A2} and {B1, B2}. The method then assumes that the counts follow the
NB distribution and derives an empirically determined prior distribution from the data.
The final component of these methods is the test for gene differential expression. Both
edgeR and DESeq use variations of Fisher’s exact test, adjusted for the NB distribution, to
compute exact p-values for the null hypothesis that the mean expressions of the genes are
equal in both conditions under comparison. EdgeR also considers the generalized linear
model approach to identify differentially expressed genes in its later versions; nevertheless,
it has been shown to have similar performance to the method based on Fisher’s exact test
[Schurch et al., 2016]. Different from edgeR and DESeq, baySeq ranks the genes based
on the inferred posterior probabilities of differential expression.
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3 Bayesian nonparametric differential expression anal-
ysis for RNA-Seq
We consider a family of NB processes, each of which can be used to describe the row-by-
row sequential construction of a sample-gene sequencing count matrix, where the addition
of a new sample (row) brings counts at not only previously expressed genes (columns), but
also previously unexpressed ones. We also describe the equivalent construction that draws
a Poisson random number of independent, and identically distributed (i.i.d.) columns
simultaneously, where each column corresponds to the counts of a gene that is expressed
at least once across all the observed samples of a group. Showing these two equivalent
constructions helps clearly understand the underlying statistical assumption made on the
RNA-Seq data by a BNP prior, and how the statistical strength is shared across both the
genes and samples to estimate both the sample-specific model parameters, which account
for the variations in sequencing depths, and the gene-specific model parameters, whose
posterior distributions are used to detect differentially expressed genes.
We explore a family of NB processes, specifically NBP, GNBP, and BNBP in this
paper. To model the gene counts in each group with the GNBP, we consider the null
hypothesis that with sample-specific NB probability parameters, the posterior distribu-
tions of the gene-specific NB shape parameters, regularized by the gamma process in the
prior, are the same across different groups; whereas with the BNBP, we consider the null
hypothesis that with sample-specific NB shape parameters, the posterior distributions
of the gene-specific NB probability parameters, regularized by the beta process in the
prior, are the same across different groups. For comparison, we also include NBP and
its scaled version, and consider the null hypothesis that the posterior distributions of
the gene-specific Poisson rate parameters of the scaled NBP, regularized by the gamma
process in the prior, or the corresponding normalized Poisson rates of the NBP, are the
same across different groups. Instead of following a standard hypothesis testing proce-
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dure to test whether two parameters are equal, in this paper, after fitting the sequencing
counts with a BNP prior, we assess the significance of gene expression changes across
groups by measuring the distances between the gene-specific posterior distributions of
the NB shape parameters for the GNBP, NB probability parameters for the BNBP, Pois-
son rates for the scaled NBP, and normalized Poisson rates for the NBP, using symmetric
Kullback-Leibler (KL) divergence [Kullback and Leibler, 1951]. Note that there are two
common ways to parameterize a NB distribution: either via both its mean µ and shape
parameter r, or via both its shape parameter r and probability parameter p. These two
different ways are related in that µ = rp/(1 − p) and the variance can be expressed as
µ + µ2/r = rp/(1 − p)2 = µ/(1 − p). We parameterize a NB distribution with both its
shape and probably parameters throughout the paper.
Below we show how a stochastic process can be used to model the counts in each
group, where the group index is omitted for brevity. We represent the counts of all
expressed genes in a group as a random count matrix NJ ∈ ZJ×KJ , where Z = {0, 1, . . .}
represents the set of nonnegative integers, KJ denotes the random number of genes
that are expressed at least once in the J samples of the group, and the element njk
represents the number of reads in sequencing sample j ∈ {1, . . . , J} that are assigned
to gene k ∈ {1, . . . , KJ}. Note that KJ , the number of expressed genes among the J
samples, is smaller or equal to K, the total number of genes in the genome, and KJ can
potentially increase without bound as J increases. For graphical illustrations of random
count matrices generated by the NBP, GNBP, and BNBP, we refer the interested readers
to Figures 1 and 2 of Zhou et al. [2016].
3.1 NBP-Seq: Negative binomial process for RNA-Seq
Let us denote G0 as a finite and continuous base measure over a complete and sepa-
rable metric space Ω, c ∈ R+ as a scale parameter, and qj ∈ R+ as sample-specific
scaling parameters, where R+ := {x : x > 0}. We define the scaled negative binomial
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process (NBP) that has sample-specific scaling parameters as
(X1, . . . , XJ) | c,G0, {qj}1,J ∼ NBP(G0, c0, q1, . . . , qJ),
which is obtained by marginalizing out a gamma process [Ferguson, 1973]G ∼ ΓP(G0, 1/c)
from J conditionally independent Poisson processes [Kingman, 1993]Xj | qj, G ∼ PP(qjG),
where for disjoint Borel sets Aj ⊂ Ω, the gamma process G is defined such that G(Ai) ∼
Gamma[G0(Ai), 1/c] are independent gamma random variables, and the Poisson process
Xj is defined such that Xj(Ai) ∼ Pois[qjG(Ai)] are independent Poisson random vari-
ables. With a draw from the gamma process expressed as G =
∑∞
k=1 rkδωk , where ωk and
rk are the atoms and their weights, respectively, a draw from Xj can be expressed as
Xj =
∞∑
k=1
njkδωk , njk ∼ Pois(qjrk). (1)
Note that if we fix qj = 1 for all j, then the proposed NBP with sample-specific scaling
parameters reduces to the NBP in Zhou and Carin [2015] and Zhou et al. [2016].
The conditional likelihood of the observed J samples of a group can be written as
p({Xj}Jj=1 |G) = e−q·G(Ω\DJ )
[
KJ∏
k=1
rn·kk e
−q·rk∏J
j=1 njk!
][
J∏
j=1
q
nj
j
]
, (2)
where DJ = {ωk}k:n·k>0 is the set of points of discontinuity, KJ = |DJ | =
∑
k δ(n·k > 0)
is the number of genes that are expressed at least once, q· =
∑J
j=1 qj, and n·k =
∑J
j=1 njk.
We map the counts associated with the elements of DJ to the random count matrix NJ .
While the labelings of the atoms in DJ are arbitrary, they are mapped in one of the KJ !
possible ways to the columns of NJ . Similar to the derivation in Zhou et al. [2016], using
a marginalization procedure shown in Caron et al. [2014], one may marginalize out the
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gamma process G, leading to the distribution of the random count matrix as
f(NJ | γ0, c, q1, . . . , qJ) = p({Xj}1,J | γ0, c, q1, . . . , qJ)
KJ !
=
γKJ0 exp
[−γ0 ln( q·+cc )]
KJ !
[
KJ∏
k=1
Γ(n·k)
(q·+c)n·k∏J
j=1 njk!
][
J∏
j=1
q
nj
j
]
. (3)
One may verify by straightforward calculation that a scaled NBP random count matrix
with the probability mass function (PMF) shown in (3) can be generated column by
column as i.i.d. count vectors:
n:k ∼ Multinomial(n·k, q1/q·, . . . , qJ/q·),
n·k ∼ Logarithmic[q·/(c+ q·)],
KJ ∼ Pois {γ0 [ln(c+ q·)− ln(c)]} . (4)
It is clear from (4) that the columns of NJ are i.i.d. multivariate count vectors, which all
follow the same logarithmic-multinomial (mixture) distribution. Thus the scaled NBP
random count matrix NJ is column exchangeable. It is also row exchangeable if and only
if the qj are the same for all j ∈ {1, . . . , J}.
Now consider the row-wise sequential construction of the scaled NBP random matrix.
With the prior on NJ ∈ ZJ×KJ well defined, straightforward calculations using (4) yield
the following form for this prediction rule, expressed in terms of familiar PMFs:
f(NJ+1 |θ)
f(NJ |θ) =
KJ !K
+
J+1!
KJ+1!
KJ∏
k=1
NB
(
n(J+1)k;n·k,
qJ+1
c+ q· + qJ+1
)
×
KJ+1∏
k=KJ+1
Logarithmic
(
n(J+1)k;
qJ+1
c+ q· + qJ+1
)
× Pois{K+J+1; γ0 [ln(c+ q· + qJ+1)− ln(c+ q·)]} , (5)
where θ := {γ0, c, q1, . . . , qJ}. This formula indicates that, to add a new row to NJ ∈
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ZJ×KJ , we first draw count NB[n·k, qJ+1/(c+q· +qJ+1)] at each existing column. We then
draw K+J+1 new columns as K
+
J+1 ∼ Pois{γ0 [ln(c+ q· + qJ+1)− ln(c+ q·)]}. Finally, each
entry in the new columns has a Logarithmic
[
n(J+1)k; qJ+1/(c+ q· + qJ+1)
]
distributed
random count. It is clear in the sequential construction of the scaled NBP random count
matrix, for a point of discontinuity ωk ∈ DJ , the variance and mean are related as
var[n(J+1)k] = E[n(J+1)k] +
E2[n(J+1)k]
n·k
. (6)
Since n·k, the total count of gene k of all the J samples of the group, is fixed, the above
equation indicates a variance and mean relationship that does not change.
3.1.1 Inference for the scaled NBP
The parameters of the scaled NBP can be inferred using Gibbs sampling with closed-
form update equations. Using likelihoods (2) and (3), with γ0 ∼ Gamma(e0, 1/f0),
c ∼ Gamma(c0, 1/d0), and qj ∼ Gamma(a0, 1/b0) in the prior, each Gibbs sampling
iteration proceeds as
(γ0 | −) ∼ Gamma
(
e0 +KJ ,
1
f0 − ln( cc+q· )
)
,
(rk | −) ∼ Gamma[n·k, 1/(c+ q·)],
[G(Ω \ DJ) | −] ∼ Gamma[γ0, 1/(c+ q·)],
(qj | −) ∼ Gamma{a0 + nj, 1/[b0 +G(Ω)]},
(c | −) ∼ Gamma{c0 + γ0, 1/[d0 +G(Ω)]}, (7)
where G(Ω) := G(Ω\DJ)+
∑KJ
k=1 rk, given which the total gene count for sample j follows
Poisson[qjG(Ω)]. Note that a gene that has at least one nonzero count among the J
samples will be attached to a discrete atom (point of discontinuity) of the gamma process
with weight rk, while all the other countably infinite unexpressed genes are associated
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with the atoms in the absolute continuous space Ω\DJ , whose total weight is G(Ω\DJ).
3.1.2 NBP-Seq differential expression analysis
To detect differentially expressed genes using the scaled NBP, we notice in the prior that
E[njk | qj, G] = var[njk | qj, G] = qjrk
and in the conditional posterior shown in (7) that
E[rk | −] = n·k/(c+ q·), E[qj | −] = (a0 + nj)/[b0 +G(Ω)]. (8)
Thus one may consider rk as a gene-specific Poisson rate parameter that indicates the
expression level of gene k, whose conditional posterior is related to both n·k, the total
count of gene k across all the J samples of the group, and q·, the total sum of the sample-
specific gamma distributed scaling parameters; one may consider qj as a scaling factor to
be inferred from the data, whose conditional posterior is determined not only by nj, the
total count of all genes in sample j that indicates the sequencing depth of sample j, but
also by G(Ω), the total sum of all countably infinite gene-specific Poisson rate parameters;
and the conditional posterior of γ0 is clearly related to KJ , the total number of expressed
genes in the group. Therefore, the scaled NBP borrows statistical strength across both
the genes and samples to infer the conditional posterior of rk.
To assess whether the difference between the expressions of the same gene at differ-
ent sample groups is statistically significant, we collect posterior Markov chain Monte
Carlo (MCMC) samples for each rk in each group, and use these MCMC samples to mea-
sure the distance between the posterior distributions of the rk of the same gene across
different groups. Note that for a gene whose total count across all samples in a group is
zero, the posterior values of its rk would be fixed at 0.
Instead of using the scaled NBP that introduces qj to model sample-specific sequencing
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depths, we also consider the original NBP of Zhou et al. [2016] with all qj fixed at one.
To compensate for the variations of sequencing depths between samples, for the original
NBP, we normalize the inferred Poisson rates rk and use them to evaluate the significance
of differential gene expressions.
3.2 GNBP-Seq: Gamma-negative binomial process for RNA-Seq
To generate the random count matrix NJ in a group, we construct a gamma-negative
binomial process (GNBP) [Zhou et al., 2016] as
Xj |G ∼ NBP(G, pj), G ∼ ΓP(G0, 1/c), (9)
where j ∈ {1, .., J} and Xj |G ∼ NBP(G, pj) is defined as a NBP such that Xj(A) ∼
NB[G(A), pj] for each Borel subset A ⊂ Ω. Note that Xj |G ∼ NBP(G, pj) can also be
augmented as a gamma process mixed sum-logarithmic process (SumLogP) as
Xj |Lj ∼ SumLogP(Lj, pj), Lj |G ∼ PP(qjG), (10)
where qj := − ln(1 − pj), i.e., pj = 1 − e−qj , and the SumLogP is defined in Zhou et al.
[2016] such that Xj(A) =
∑Lj(A)
t=1 ut, ut ∼ Logarithmic(pj) for each Borel subset A ⊂ Ω.
Thus the GNBP also can be expressed as a NBP mixed SumLogP as
Xj |Lj ∼ SumLogP(Lj, pj), (L1, . . . , LJ) ∼ NBP(G0, c, q1, . . . , qJ). (11)
With a draw from the gamma process G expressed as G =
∑∞
k=1 rkδωk , a draw from
Xj can be expressed as
Xj =
∞∑
k=1
njkδωk , njk ∼ NB(rk, pj). (12)
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The GNBP employs sample-specific NB probability parameters pj to model row hetero-
geneity. In the context of RNA-Seq data, the variations of pj can be used to account for
those of sequencing depths.
Both the row-wise and column-wise constructions of the GNBP random count matrix
mimic these of the NBP random count matrix. They are described in detail in Zhou et al.
[2016] and hence omitted here for brevity. We mention that the two key differences in
their row-wise sequential constructions are that the GNBP uses the gamma-NB instead
of NB distributions to model the counts at previously expressed genes brought by a new
sample, and the GNBP uses the logarithmic mixed sum-logarithmic instead of logarithmic
distributions to model the counts at newly expressed genes brought by a new sample.
As shown in Zhou et al. [2016], in the sequential construction of the GNBP random
count matrix, for a point of discontinuity ωk ∈ DJ , the variance and mean are related as
var[n(J+1)k] =
E[n(J+1)k]
1− pJ+1 +
E2[n(J+1)k]
l·k
, (13)
which depends on both pJ+1 and l·k that are random, where l·k :=
∑J
j=1 ljk, ljk ∼
CRT(njk, rk), with the Chinese Restaurant Table (CRT) distribution defined in the Ap-
pendix. Comparing (6) and (13), it is clear that since pJ+1 < 1 and l·k ≤ n·k, the GNBP
can model much more over-dispersed counts than the NBP.
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3.2.1 Inference for the GNBP
Letting γ0 ∼ Gamma(e0, 1/f0), pj ∼ Beta(a0, b0), and c ∼ Gamma(c0, 1/d0) in the prior,
as in Zhou et al. [2016], a Gibbs sampling iteration for the GNBP proceeds as
(γ0 | −) ∼ Gamma
(
e0 +KJ ,
1
f0 − ln( cc+q· )
)
,
(ljk | −) ∼ CRT(njk, rk), (rk | −) ∼ Gamma
[
l·k, 1/(c+ q·)
]
,
{G(Ω\DJ) | −} ∼ Gamma
[
γ0, 1/(c+ q·)
]
,
(pj | −) ∼ Beta
[
a0 + nj, b0 +G(Ω)
]
,
(c | −) ∼ Gamma{c0 + γ0, 1/[d0 +G(Ω)]}. (14)
Note that given G(Ω), the total gene count for sample j follows NB[G(Ω), pj].
3.2.2 GNBP-Seq differential expression analysis
In the GNBP, since in the prior we have
E[njk |G, pj] = rk pj
1− pj ,
var[njk |G, pj] = rk pj
(1− pj)2 = E[njk |G, pj] + r
−1
k E
2[njk |G, pj],
and in the conditional posterior, if b0 +G(Ω) > 1, we have
E[rk | −] = l·k/(c+ q·), E[pj/(1− pj) | −] = (a0 + nj)/[b0 +G(Ω)− 1]. (15)
Thus one may interpret pj/(1− pj) as a term that accounts for the sequencing depth of
sample j, and may compare the posterior distributions of the NB shape parameter rk
of the same gene at different groups to assess differential expression of that gene. The
conditional posterior of the scaling factor pj/(1 − pj) is determined by not only nj, the
15
total counts of genes in sample j, but also G(Ω), the total sum of all countably infinite
gene-specific NB shape parameters; and the conditional expectation of rk is related to
both l· and q·, which aggregate their corresponding sample-specific values across all the
J samples. Therefore, the GNBP borrows statistical strength across both the genes and
samples to infer the conditional posterior of rk. For an unexpressed gene, whose total
count across all samples in a group is 0, the posterior values of its rk would be fixed at 0.
Comparing (8) and (15) shows that both the GNBP and scaled NBP have similar
sample-specific scaling parameters, but, as in (14), since E[ljk | −] =
∑njk
t=1 rk/(rk + t− 1)
and hence E[ljk | −] ≈ rk ln(njk + rk) for large njk, the posteriors of the gene-specific
parameters rk in the GNBP would be impacted much less by some genes whose expres-
sions njk are significantly larger than their mean expression levels, which are commonly
observed in genomic studies.
3.3 BNBP-Seq: Beta-negative binomial process for RNA-Seq
Similar to the GNBP, the BNBP can be used to model RNA-Seq samples. The BNBP
can be constructed by sharing the NB probability parameters across the J sequencing
samples of the same group as
Xj | rj, B ∼ NBP(rj, B), B ∼ BP(c, B0), (16)
where j ∈ {1, . . . , J} and B ∼ BP(c, B0) is a beta process with a finite and continuous
base measure B0 over Ω and a concentration parameter c, with Le´vy measure
ν(dpdω) = p−1(1− p)c−1dpB0(dω). (17)
With a draw from the beta process B expressed as B =
∑∞
k=1 pkδωk , where ωk and pk
are atoms and their associated probability weights, respectively, a draw from Xj given B
can be expressed as
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Xj =
∞∑
k=1
njkδωk , njk ∼ NB(rj, pk). (18)
In the BNBP, different rj’s are used to model the sequencing depth variations.
Both the row-wise and column-wise constructions of the BNBP random count matrix,
as described in detail in Zhou et al. [2016] and hence omitted here for brevity, mimic these
of the scaled NBP random count matrix. We mention that the two key differences in
their row-wise sequential constructions are that the BNBP uses the beta-NB instead of
NB distributions to model the counts at previously expressed genes brought by a new
sample, and the BNBP uses the digamma instead of logarithmic distributions to model
the counts at newly expressed genes brought by a new sample.
As shown in Zhou et al. [2016], in the sequential construction of the BNBP random
count matrix, for a point of discontinuity ωk, the variance and mean are related as
var[n(J+1)k] =
E[n(J+1)k]
c+r·−2
n·k+c+r·−1
+
E2[n(J+1)k]
n·k(c+r·−2)
n·k+c+r·−1
, (19)
which depends on both c and r· that are random. Comparing (6) and (19), it is clear
that since c+r·−2
n·k+c+r·−1 ≤ 1 and
n·k(c+r·−2)
n·k+c+r·−1 < n·k for c + r· > 2, similar to the GNBP, the
BNBP can also model much more over-dispersed counts than the scaled NBP.
The variance-mean relationships expressed by (6), (13), and (19) show that the GNBP
and BNBP can model much more over-dispersed counts than the (scaled) NBP, and as
shown in Figure 1 of Zhou et al. [2016], given the same expected total count, while the
counts in NBP random count matrices usually have small dynamic ranges, the counts
in both the GNBP and BNBP matrices can contain values that are significantly above
the average. In RNA-Seq, it is common to have large dynamical range for highly over-
dispersed gene counts, which are likely to be better modeled by both the GNBP and
BNBP than by the (scaled) NBP, as confirmed by our experiments in Section 4.
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3.3.1 Inference for the BNBP
Letting γ0 ∼ Gamma(e0, 1/f0), pj ∼ Beta(a0, b0), and c ∼ Gamma(c0, 1/d0), as in Zhou
et al. [2016], a Gibbs sampling iteration for the BNBP proceeds as
(γ0 | −) ∼ Gamma
(
e0 +KJ ,
1
f0 + ψ(c+ r·)− ψ(c)
)
,
(pk | −) ∼ Beta(n·k, c+ r·), (p∗ | −) ∼ logBeta(γ0, c+ r·),
(ljk|−) ∼ CRT(njk, rj),
(rj | −) ∼ Gamma
(
a0 + lj·,
1
b0 + p∗ −
∑KJ
k=1 ln(1− pk)
)
. (20)
Inside each Gibbs sampling iteration, as in Zhou et al. [2016], an independence chain
Metropolis-Hastings sampling step can be used to update the concentration parameter c.
3.3.2 BNBP-Seq differential expression analysis
In the BNBP, since in the prior we have
E[njk | rj, B] = rj pk
1− pk , var[njk | rj, B] = rj
pk
(1− pk)2 = (1− pk)
−1E[njk | rj, B], (21)
and in the conditional posterior, if c+ r· > 1, we have
E[pk/(1− pk) | −] = n·k/(c+ r· − 1), E[rj | −] = a0 + lj·
b0 + p∗ −
∑KJ
k=1 ln(1− pk)
. (22)
Thus one may consider that the NB sample-specific shape parameter rj accounts for the
sequencing depth of sample j, and may compare the posterior distributions of pk/(1−pk)
to evaluate differential expression of gene k between different groups. The posterior
expectation of rj in the BNBP is related to the NB probability parameters of all genes,
which themselves are related to r·, the aggregation of the sample-specific scaling factors
across all J samples. Thus the BNBP borrows statistical strength across all the genes and
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samples to infer the posterior distribution of pk/(1 − pk). Note that for an unexpressed
gene, whose total count across all samples in a group is 0, the posterior values of its pk
would be fixed at 0.
Comparing (8) and (22) shows that the BNBP and scaled NBP have similar gene-
specific parameters, but, as in (20), since E[ljk | −] ≈ rj ln(njk+rj) for large njk, for some
genes whose expressions njk are significantly larger than the mean expression levels, the
posteriors of the sample-specific parameters rj in the BNBP also would be impacted much
less than these of the sample-specific parameters qj in the scaled NBP.
3.4 Distance between posterior distributions
In order to compare the posterior distributions, we use the symmetric Kullback-Leibler
(KL) divergence defined between two discrete distributions P and Q as
KL(P,Q) =
∑
x
[
p(x)− q(x)] log [p(x)/q(x)].
Supposing r is the parameter to be compared between two different groups, we esti-
mate the symmetric KL-divergence between the posterior distributions of r(1) and r(2),
the values of r of the first and second groups, respectively, using collected MCMC sam-
ples. We first find both the minimum and maximum values of the MCMC samples of r
across both groups to define an interval for r. After adjusting the lower- and upper-limits
of the interval as [max(0, Q1− 1.5 ∗Q4), Q3 + 1.5 ∗Q4], where Q1 and Q3 are 25% and
75% quantiles and Q4 = Q3 −Q1, we equally divide the adjusted interval into N = 100
bins. For each group, we count the number of MCMC samples falling into each bin, and
then normalize these bin counts to a 100 dimensional discrete probability vector, referred
to as pi(1) and pi(2) for the first and second groups, respectively. Finally, with a small
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constant set as  = 10−10, we calculate the symmetric KL-divergence as
KL(pi(1),pi(2)) =
N∑
i=1
(
pi
(1)
i − pi(2)i
)
log
(pi(1)i + 
pi
(2)
i + 
)
. (23)
4 Experimental Results
To evaluate the proposed BNP differential expression analysis algorithms, we compare
their performance on both synthetic and real-world benchmark RNA-Seq data with those
of edgeR [Robinson et al., 2010], DESeq [Anders and Huber, 2010], and baySeq [Hardcas-
tle and Kelly, 2010], three widely used algorithms in biomedical studies. We also present
a case study on clear cell renal cell carcinoma (ccRCC) [Cancer Genome Atlas Research
Network et al., 2012], explaining the biomedical implications obtained by differential ex-
pression analysis using both our GNBP and BNBP methods. We first consider synthetic
RNA-Seq data generated under different models, and we show that the proposed GNBP
and BNBP differential expression analysis algorithms consistently provide outstanding
performance. We then consider the real-world benchmark RNA-Seq data extracted from
the SEquencing Quality Control (SEQC) project [Xu et al., 2013, SEQC/MAQC-III
Consortium, 2014] and the ccRCC case study extracted from The Cancer Genome Atlas
(TCGA) [McLendon et al., 2008]. We consider the RNA-Seq data from both Beijing
Genomics Institute (BGI) and the Pennsylvania State University (PSU) provided in the
SEQC project [Xu et al., 2013, SEQC/MAQC-III Consortium, 2014], available in the
R package SEQC on Bioconductor [Gentleman et al., 2004]. Both the BGI and PSU
datasets, which are the transcriptomic expression measurements of the RNA samples
prepared at the same biological conditions but sequenced at different sequencing sites,
contain the counts for approximately 26,000 genes. In our experiments, we employ sam-
ple groups A and B, which are derived from Agilent’s Universal Human Reference RNA
and Life Technologies’ Human Brain Reference RNA cell lines, respectively. We collect
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the counts from the first flow cells of the sequencing machines on five replicates for each
group (condition).
On both synthetic and real-world RNA-Seq count data, comparison of both the area
under the receiver operating characteristic (ROC) curve (AUC-ROC) and area under
the precision-recall (PR) curve (AUC-PR) shows that the proposed GNBP and BNBP
algorithms clearly outperform the (scaled) NBP and previously proposed differential ex-
pression analysis algorithms, as described below in detail.
4.1 Synthetic data
We first generate synthetic RNA-Seq data with the GNBP generative model, the BNBP
generative model, or the NB distribution based procedure adopted in baySeq [Hardcastle
and Kelly, 2010]. For each setting, to make the synthetic data closely resemble real-world
RNA-Seq data, we first infer the parameters of the corresponding model on the BGI or
PSU datasets from SEQC, and then generate synthetic sequencing counts using these
inferred model parameters. To simulate samples from two different groups (conditions),
each of which has 10,000 genes in five replicates, we randomly select 10% of the genes and
set them to be differentially expressed between the two groups, with the fold change of
differentially expressed genes chosen as an adjustable parameter. For quality control, we
discard the bottom 10% of genes with low expressions across groups in data generation.
In order to produce both up- and down-regulated differentially expressed genes, each
differentially expressed gene is randomly set to be either up- or down-regulated. Below
we denote b > 1 as the fold change to be set. We use the PSU dataset for the baySeq
setting and the BGI dataset for both the GNBP and BNBP settings. Using different
datasets to infer model parameters and different models to generate synthetic datasets
allows us to assess the robustness of various methods in different practical settings.
In the GNBP setting, if gene k is up-regulated, then we generate its counts using
NB(rk, pj) and NB(b rk, pj) for the samples in the first and second groups, respectively;
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whereas if gene k is down-regulated, then we generate its counts using NB(rk, pj) and
NB(rk/b, pj) for the five samples in the first and second groups, respectively.
In the BNBP setting, if gene k is up-regulated, then we generate its counts using
NB(rj, pk) and NB(rj, p
′
k), where p
′
k is selected to satisfy bpk/(1−pk) = p′k/(1−p′k), for the
samples in the first and second groups, respectively; whereas if gene k is down-regulated,
then we generate its counts using NB(rj, p˜k) and NB(rj, pk), where p˜k is selected to satisfy
pk/(1−pk) = bp˜k/(1−p˜k), for the five samples in the first and second groups, respectively.
In the baySeq setting of Hardcastle and Kelly [2010] that generates a count from a
NB distribution given its mean and dispersion parameters, if gene k is up-regulated, then
we generate its counts using µk and bµk as the means for the first and second groups,
respectively; whereas if gene k is down-regulated, then we generate its counts using µk
and µk/b as the means for the first and second groups, respectively.
We infer the model parameters via Gibbs sampling for the proposed BNP differential
expression analysis algorithms. For each algorithm, we collect 1,000 MCMC samples
after 1,000 burn-in iterations. The example MCMC sample trace plots in Figure 5 of
the Appendix suggest that the Markov chains for both the GNBP and BNBP methods
converge fast and mix well, supporting the practice of performing downstream analysis
with 2,000 MCMC iterations. For the analysis of the real-world dataset BGI on a single
cluster node with Intel Xeon 2.5GHz E5-2670 v2 processor, it took around two hours for
both the GNBP and BNBP methods with 2,000 MCMC iterations, about ten minutes
for the other methods, including the NBP. Note that parallelization could further speed
up the inference. We use the collected MCMC samples to calculate the symmetric KL
divergence, as in (23), between two groups for each gene, and rank the genes according to
these values. For edgeR and DESeq, we follow the standard analysis pipelines and rank
the genes using the computed p-values; and for baySeq, we rank the genes using model
likelihoods. We set the fold change b as 1.4, 1.6, 1.8, or 2 in simulating synthetic data
to assess how sensitive the algorithms under study are to different levels of differential
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expression. For each fold change, we report the results of each algorithm based on ten
independent random trials.
For these three different types of synthetic data, as shown in Figure 1, measured by
both AUC-ROC and AUC-PR, baySeq has the worst overall performance even when the
synthetic data are generated based on its model assumption, followed by the scaled NBP;
the NBP, DESeq, and edgeR all have similar performance; and the GNBP and BNBP
clearly outperform all the other differential expression analysis algorithms. To further
compare the operating characteristics of different algorithms, we show in Figure 4 in the
Appendix the full ROC and PR curves for the fold change of b = 1.8. We provide in
the Appendix the detailed numerical values used to plot Figure 1, as shown in Tables
1-6, where for each setting the best result and the ones that are less than one standard
deviation away from the best are highlighted in bold.
More carefully examining Figures 1 and 4, it is interesting to notice that for the syn-
thetic data generated with either the GNBP or BNBP, the scaled NBP, which extends
the original NBP with sample-specific scaling parameters qj to model sample sequencing
depth variations, in fact clearly underperforms the original NBP. Suggesting that explic-
itly modeling the sample sequencing depths, using the gamma-Poisson construction of
the scaled NBP, is insufficient to model the over-dispersed gene counts generated using
the gamma- or beta-NB constructions.
While the original NBP fixes qj = 1 and hence does not explicitly model the sample
sequencing depth variations, it performs as well as both DESeq and edgeR in all three
settings, which may be explained by the fact that it normalizes the posterior Poisson
rates before applying them to compare the gene expression levels between two groups, a
post-processing step that plays a similar role as the pre-processing normalization steps
used in both DESeq and edgeR to account for different sequencing depths.
It is also interesting to notice that while the GNBP consistently ranks the best or
very close to the best, in terms of both AUC-ROC and AUC-PR, the BNBP does so only
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Figure 1: left column: AUC-ROC values, right column: AUC-PR values. Performance
comparison of different methods in detecting differentially expressed genes under various fold
changes, using synthetic data generated under three different negative binomial distribution
based models.
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in terms of AUC-ROC. For synthetic data generated using the GNBP and baySeq, the
performance of the BNBP in terms of AUC-PR quickly deteriorates as the fold change
reduces from 1.8 to 1.4, suggesting a large number of false positives among the top ranked
genes of the BNBP when the fold change is not sufficiently large for the GNBP synthetic
data. The disparity between the performance measured by AUC-ROC and that measured
by AUC-PR, which only happens for the BNBP, indicates that the BNBP employs a
distinct mechanism to detect differentially expressed genes, as carefully discussed below.
To compare the expression levels of the kth gene between two groups, the GNBP com-
pares the posterior NB shape parameters rk, whereas the BNBP compares the posterior
NB probability parameters pk. One may consider that the expression level of gene k is
assumed to roughly follow a smooth function of the shape parameter rk in the GNBP,
and a smooth function of pk/(1− pk) in the BNBP. The difference between the posterior
NB shape parameters rk explains the differences between both the means and dispersions,
but does not explain that of the variance-to-mean ratios (VMR), of the counts of gene k
at different groups, since if njk ∼ NB(rk, pj), then E[njk] = rkpj/(1 − pj), var[njk] =
E[njk] + (E[njk])2/rk, and VMR[njk] = 1 +E[njk]/rk; whereas the difference between the
posterior NB probability parameters pk explains the differences between both the means
and VMRs of the counts of gene k at different groups, since if njk ∼ NB(rj, pk), then
E[njk] = rjpk/(1 − pk), var[njk] = E[njk] + (E[njk])2/rj, and VMR[njk] = 1/(1 − pk).
Therefore, for the counts of a gene generated with the GNBP, if the rk is small, a small
change in its value may lead to a significant change of VMR[njk] = 1+(E[njk])/rk, which
implies that a large difference in a gene’s VMRs between two groups may not be taken
by the GNBP as a strong evidence for differential expression. By contrast, since the
gene-specific parameter pk in the BNBP is explicitly responsible for the VMR, a large
difference in a gene’s VMRs between two groups may encourage the BNBP to rank that
gene as strongly differentially expressed, which may be used to explain why the BNBP
has good AUC-ROC but poor AUC-PR if the fold change is small for the GNBP synthetic
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data. In practice, however, it is often unclear whether it is the change of the quadratic
relationship between the variance and mean, as captured by the NB dispersion param-
eter, or the VMR, as captured by the NB probability parameter, that is responsible for
the change of a gene’s expression level. Thus it is often unclear whether the GNBP or
BNBP would be a better choice for a real dataset, and it seems promising to combine
the advantages of both for differential expression analysis, an attractive research topic
beyond the scope of the paper that is to be investigated in our future study.
To more comprehensively evaluate the proposed methods, we consider several addi-
tional application scenarios. The performance comparisons with baySeq synthetic data
under these different scenarios are shown in Figure 6 in the Appendix. We first assess the
sensitivity of different methods to the ratio of up- and down-regulated genes among the
set of truly differentially expressed genes, which, the same as before, take 10% of the total
number of genes. We assume a fold change of 2 for these truly differently expressed genes,
and vary the percentage of up-regulated (down-regulated) genes among them from 20%
(80%) to 40% (60%), 60% (40%), and 80% (20%). As shown in Figure 6(a), while the
GNBP, BNBP, edgeR, and DESeq all show robustness to the change of that percentage,
the performance of both the NBP based and baySeq methods significantly deteriorates as
one increases the imbalance between the numbers of up- and down-regulated genes. We
also note that both the GNBP and BNBP successfully preserve their out-performance
margins under various ratios of up- to down-regulated genes.
To examine how the performance changes with the sample size, we consider increasing
the number of samples for each group from 4, to 8, 12, and 16. This is a sensible choice,
since in practice the number of samples per condition is often smaller than 16. In this
experiment, 10% of genes are equally likely to be up- or down-regulated with a fold change
of 2. Figure 6(b) illustrates the error bar plots for both the AUC of ROC curve and
that of PR curve, under different sample sizes over 10 random trials. All methods show
consistent improvements as the number of replicates in each group increases, which agrees
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with the expectation that more samples provide more information to assist parameter
inference. In addition, we consider 100 genes with different sample sizes to investigate
the performance of the proposed methods in the setting with a large sample size but a
small number of genes. Similar to previous simulations, 10% of the genes are assumed to
be differentially expressed with a fold change of 2, and the number of replicates in each
group is increased from 4 to 6, 8, 10, 20, 40, 60, 80, and 100. Figure 7 shows the error
bar plots for both the AUC of ROC curve and that of PR curve, under different sample
sizes over 10 random trials. As expected, adding more samples consistently enhances the
recovery of true differential expression state of the genes for all methods, and when the
number of samples reaches 100, almost all methods perform perfectly.
Last but not least, Figure 6(c) shows the box plots of the AUCs of ROC and PR curves
when the true fold change of differentially expressed genes is uniformly distributed within
the interval [1.4, 2]. The BNBP stands out as the best performing method followed by
the GNBP, suggesting that the superior results of the proposed methods in previous
simulations do not rely on setting the fold change to a fixed constant.
4.2 SEQC benchmark RNA-Seq data and case study
In order to characterize various RNA-Seq technologies and quantification pipelines in
the SEQC project [Xu et al., 2013, SEQC/MAQC-III Consortium, 2014], the same RNA
samples for a comprehensive group of control genes are analyzed based on quantitative Re-
verse Transcription Polymerase Chain Reaction (qRT-PCR) using TaqMan assays [Joyce,
2002], which is referred as the TaqMan benchmark data [Shi et al., 2006, MAQC Consor-
tium, 2010]. For sample groups A and B, the expression intensity values of 955 selected
control genes have been derived in the TaqMan qPT-PCR analysis for sequencing bench-
marking. Without knowing in practice which genes are truly differentially expressed
between different conditions, we consider thresholding the qRT-PCR expression ratios
between different conditions at a certain value to define the ground-truth set of differen-
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tially expressed genes. Based on these 955 genes in the TaqMan data, we evaluate the
performance of different differential expression analysis pipelines. Note that although the
replicates in SEQC are technical, they show notable amount of over-dispersion and have
been used in the literature as a standard benchmark for assessing differential expression
analysis tools [Rapaport et al., 2013].
While it is unknown which genes are truly differentially expressed for both the BGI
and PSU RNA-Seq data, we rely on the qRT-PCR expression intensity of the 955 genes
in the TaqMan data and set different cut-offs for the binary logarithm (log2) of the
qRT-PCR expression ratio to define “truly” differentially expressed genes. We increase
this log2 cut-off value gradually from 0.5 to 2, and calculate both AUC-ROC and AUC-
PR. The symmetric KL divergence is used to assess differential expression. As shown
in Figure 2 for both the BGI and PSU datasets, the GNBP and BNBP outperform all
the other methods in both ROC and PR analyses with significant margins. Note that
the performance gains of the GNBP and BNBP over the other methods become more
significant as one increases the log2 cut-off for the qRT-PCR expression ratio, which
reduces the number of genes that are considered as truly differentially expressed.
Comparing Figure 1 for synthetic data with Figure 2 for real-world data, one may
notice that while both the AUC-ROC and AUC-PR curves in Figure 1 seem to monotoni-
cally increase as the fold change increases, the AUC-ROC and AUC-PR curves in Figure 2
do not necessarily share similar trends. It is not surprising to observe these seemingly
distinct behaviors, since for the synthetic data in Figure 1, the set of truly differentially
expressed genes are fixed and known exactly, remaining unchanged regardless of how one
sets the fold change that is used to detect differentially expressed genes, whereas for the
real-world data in Figure 2, the number of genes considered as truly expressed reduces
as the cut-off value of the qRT-PCR expression ratio increases. In addition, we note
that the results of edgeR, DESeq, and baySeq on both the BGI and PSU real datasets
reported in this paper are similar to those reported in Rapaport et al. [2013].
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Figure 2: left column: AUC-ROC values, right column: AUC-PR values. Performance
comparison of different methods in detecting differentially expressed genes on real-world
benchmark RNA-Seq data from the SEQC project.
To investigate the experimental results more thoroughly, we fix the true positives and
negatives at the log2 cut-off value of 2 and illustrate the ROC and PR curves for BGI
dataset in Figure 3. In addition, we show in Table 7 the area under the ROC curve for
the range with FPR ≤ 0.1 and area under the PR curve for the range with Recall ≤ 0.1
for various algorithms. It is clear that both the GNBP and BNBP not only have higher
AUC-ROC and AUC-PR, but also outperform all the other methods in almost all regions
of the ROC and PR curves.
In addition to showing the ROC and PR curves, we also plot the number of false
discoveries to highlight the performance on the top ranked genes. Since there are 400
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Figure 3: left: ROC curves, right: Precision-Recall (PR) curves. Performance compar-
ison of different methods with the log2 cut-off value fixed at 2 for the BGI dataset from
the SEQC project.
truly differentially expressed genes based on the log2 cut-off value of 2, the top 400 genes
detected by each approach are selected and the number of false discoveries are plotted.
It is clear from Figure 8 in the Appendix that both the GNBP and BNBP return much
smaller number of false positives in comparison to all the other differential expression
analysis algorithms.
4.3 Case study: clear cell renal cell carcinoma
For further illustration, we provide a case study with both the GNBP and BNBP methods
on clear cell renal cell carcinoma (ccRCC), the most common type of kidney cancer that
is closely related to genes involved in regulating cellular metabolism [Cancer Genome
Atlas Research Network et al., 2012]. We collect 21 samples from The Cancer Genome
Atlas (TCGA) [McLendon et al., 2008], 11 of which are from the patients diagnosed with
ccRCC and kidney as the primary site before any treatment procedures and the remaining
10 samples are from normal persons. These samples contain roughly 1.2 billion reads
mapped to one of the 60,843 genomic locations annotated by the Ensembl database. The
raw counts produced by HTSeq [Anders et al., 2014] are downloaded from the TCGA
Website (see https://gdc-portal.nci.nih.gov/). We first filter out the genes whose total
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counts over all samples are less than 20. We apply both the GNBP and BNBP methods to
detect differentially expressed genes, where after 1,000 burn-in iterations, 1,000 posterior
samples are collected to calculate the KL-divergence between two different conditions
to rank the genes. Similar to EdgeR and DESeq, our BNP based methods provide new
statistical tools for differential expression analysis of RNA-Seq data and can help identify
critical biomarkers in biomedical applications.
The top differentially expressed gene identified by the BNBP method is Interleukin-
32 (IL-32), a proinflammatory cytokine that acts as a significant pathogenetic factor in
various diseases and malignancies. It is reported as a potential prognostic factor for
predicting outcomes in patients with ccRCC [Lee et al., 2012]. The third gene in the
ranking list is FHL1, for which clinical analyses suggest its expression is suppressed in
some human tumors, including those of the breast, kidney, and prostate and it suppresses
metastatic cell growth [Li et al., 2008]. The fourth gene, VIM, is another potential
oncogene regulated by tumor suppressive microRNA-138 [Yamasaki et al., 2012]. The
fifth gene, Progranulin (PGRN), is a pluripotent secreted growth factor that mediates cell
cycle progression and cell motility, and is highly expressed in aggressive cancer cell lines
and clinical specimens, including breast, ovarian, and renal cancers as well as gliomas [He
and Bateman, 2003]. The ninth gene, SLC12A1, is a tumor suppressor that is reported
to lose its function in ccRCC as a result of increased levels of some microRNAs such as
miR-142-3p and miR-185 [Liu et al., 2010]. The tenth gene, PGK1, is a target gene of
MYC pathway, which potentially has an essential role in the proliferation of ccRCC cells
[Tang et al., 2009].
The top differentially expressed gene identified by the GNBP method is UMOD, en-
coding uromodulin, the major protein secreted in the normal urine that has a link to
kidney chronic disease. It has been considered as a potential therapeutic target to pre-
serve renal function [Trudu et al., 2013]. The fourth gene, MT-ND4, is a mitochondrial
gene whose mutation leads to complex I enzyme deficiency found in renal oncocytoma
31
[Gasparre et al., 2008]. The seventh gene, AQP2, involved in regulating the homeostasis
of water-electrolyte balances has been found to be the most significantly down-regulated
in ccRCCs [Zhou et al., 2010]. The ninth gene, COX-2 is associated with several clinico-
pathological factors, and is conjectured to play an important role in tumor cell prolifer-
ation and MMP-2 expression [Miyata et al., 2003].
In addition to these top ranked genes, several other important genes, previously shown
to have strong connections to renal cell carcinoma, are also ranked in the top 5% by
both the GNBP and BNBP methods. In the following we list some well-studied ccRCC
biomarkers or genetic risk factors in the literature.
• The CA9 gene, whose corresponding encoded protein is a tumor-associated anti-
gen, is well known in the literature as a reliable diagnostic biomarker of clear cell
carcinoma of kidney [Liao et al., 1997, Bui et al., 2003].
• The MT1G gene has been demonstrated to have frequent occurrence of Methylation
of CpG dinucleotides in the promoter region, which is a major mechanism of tumor
suppressor genes inactivation in renal cell carcinoma [Morris et al., 2003].
• A member of the AP-2 family of transcription factors, TFAP2B, functions as both a
transcriptional activator and repressor, required for proper terminal differentiation
and function of renal tubular epithelia for the survival of renal epithelial cells during
renal development [Tun et al., 2010]. Its down-regulation in ccRCC has been verified
by Microarray profiling and PCR [Tun et al., 2010].
• The DACH1 gene is a molecular marker of renal cell carcinoma where its expres-
sion remarkably decreases and the restoration of DACH1 function in renal clear
cell cancer cells inhibits in vitro cellular proliferation, S phase progression, clone
formation, and in vivo tumor growth [Chu et al., 2014].
• ANGPT2 is a member of the angiopoietin family, which plays a pivotal role in
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angiogenesis during cancer development and metastasis [Lu et al., 2014]. Upregu-
lation of ANGPT2 has been reported in various human cancers including renal cell
carcinoma [Bullock et al., 2010, Baldewijns et al., 2007].
5 Conclusions
We exploit Bayesian nonparametric priors, including the gamma-Poisson, gamma-negative
binomial, and beta-negative binomial processes, to model RNA sequencing count matri-
ces. With different sequencing depths captured by sample-specific model parameters,
the posterior distributions of certain gene-specific model parameters are used to detect
the genes that are differentially expressed between different conditions. With the model
parameters inferred by borrowing statistical strength across both the genes and samples,
there is no need to adjust the raw counts using heuristics before downstream analyses, an
important pre-processing step that is often required in previously proposed algorithms.
Example results on both synthetic and real-world RNA-Seq data demonstrate the state-
of-the-art performance of both the gamma- and beta-negative binomial processes based
differential expression analysis algorithms. Given the success of the proposed random-
process-based algorithms in differential expression analysis, it is of interest to investigate
Bayesian nonparametric algorithms for many other real-world applications in biomedicine
that require analyzing next-generation sequencing data.
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A Chinese restaurant table (CRT) distribution
The negative binomial distribution m ∼ NB(r, p) with the probability mass function
fM(m) =
Γ(m+ r)
m!Γ(r)
(1− p)rpm, m ∈ {0, 1, . . .}
can be augmented as a gamma mixed Poisson distribution as
m ∼ Pois(λ), λ ∼ Gamma(r, p/(1− p)),
where the gamma distribution is parametrized by its shape r and scale p/(1− p). It can
be augmented under a compound Poisson representation as
m =
∑`
t=1
ut, ut ∼ Log(p), ` ∼ Pois(−r ln(1− p)),
where u ∼ Log(p) is the logarithmic distribution with probability generation function
CU(z) = ln(1 − pz)/ ln(1 − p), |z| < p−1. As in Zhou and Carin [2015], we denote
the conditional posterior distribution of ` given m and r by (` |m, r) ∼ CRT(m, r) and
sample it with the summation of independent Bernoulli random variables as ` =
∑m
n=1 bn,
bn ∼ Bernoulli[r/(n− 1 + r)].
B Additional tables and figures
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Table 1: AUC-ROC in the GNBP simulation setup for different true fold changes.
Fold change
Method 1.4 1.6 1.8 2
GNBP 0.9226 ± 0.006 0.9625 ± 0.003 0.9777 ± 0.003 0.9864 ± 0.002
BNBP 0.9156 ± 0.005 0.9610 ± 0.003 0.9783 ± 0.002 0.9875 ± 0.002
edgeR 0.9004 ± 0.007 0.9463 ± 0.004 0.9653 ± 0.003 0.9778 ± 0.003
DESeq 0.8986 ± 0.008 0.9444 ± 0.004 0.9634 ± 0.003 0.9764 ± 0.003
baySeq 0.7542 ± 0.008 0.8247 ± 0.012 0.8752 ± 0.003 0.9114 ± 0.008
NBP 0.9035 ± 0.007 0.9476 ± 0.004 0.9665 ± 0.003 0.9786 ± 0.003
NBPscaled 0.8596 ± 0.014 0.8990 ± 0.017 0.9366 ± 0.009 0.9506 ± 0.0053
Table 2: AUC-PR in the GNBP simulation setup for different true fold changes.
Fold change
Method 1.4 1.6 1.8 2
GNBP 0.7873 ± 0.011 0.8998 ± 0.006 0.9382 ± 0.003 0.9607 ± 0.003
BNBP 0.5660 ± 0.011 0.8189 ± 0.008 0.9213 ± 0.005 0.9563 ± 0.002
edgeR 0.7857 ± 0.015 0.8742 ± 0.007 0.9136 ± 0.003 0.9403 ± 0.003
DESeq 0.7848 ± 0.014 0.8714 ± 0.007 0.9107 ± 0.002 0.9369 ± 0.004
baySeq 0.6517 ± 0.012 0.7655 ± 0.015 0.8329 ± 0.003 0.8756 ± 0.004
NBP 0.7934 ± 0.014 0.8770 ± 0.007 0.9156 ± 0.003 0.9399 ± 0.003
NBPscaled 0.6822 ± 0.035 0.7515 ± 0.036 0.8298 ± 0.028 0.8533 ± 0.012
Table 3: AUC-ROC in the BNBP simulation setup for different true fold changes.
Fold change
Method 1.4 1.6 1.8 2
GNBP 0.9648 ± 0.001 0.9847 ± 0.001 0.9914 ± 0.0014 0.9968 ± 0.001
BNBP 0.9635 ± 0.001 0.9848 ± 0.002 0.9922 ± 0.0009 0.9971 ± 0.0009
edgeR 0.9399 ± 0.001 0.9706 ± 0.003 0.9829 ± 0.0017 0.9929 ± 0.00189
DESeq 0.9383 ± 0.002 0.9694 ± 0.003 0.9818 ± 0.0016 0.9920 ± 0.0018
baySeq 0.7919 ± 0.007 0.8699 ± 0.07 0.9167 ± 0.007 0.9590 ± 0.0041
NBP 0.9438 ± 0.001 0.9729 ± 0.003 0.9844 ± 0.002 0.9935 ± 0.0016
NBPscaled 0.8939 ± 0.0107 0.9499 ± 0.0092 0.9606 ± 0.0094 0.9811 ± 0.008
Table 4: AUC-PR in the BNBP simulation setup for different true fold changes.
Fold change
Method 1.4 1.6 1.8 2
GNBP 0.8632 ± 0.011 0.9431 ± 0.005 0.9703 ± 0.003 0.9881 ± 0.002
BNBP 0.8356 ± 0.012 0.9432 ± 0.003 0.9725 ± 0.002 0.9889 ± 0.003
edgeR 0.8674 ± 0.006 0.9275 ± 0.005 0.9557 ± 0.003 0.9783 ± 0.004
DESeq 0.8634 ± 0.004 0.9240 ± 0.005 0.9523 ± 0.003 0.9759 ± 0.003
baySeq 0.7413 ± 0.015 0.8408 ± 0.01 0.8963 ± 0.007 0.9434 ± 0.003
NBP 0.8708 ± 0.006 0.9302 ± 0.005 0.9577 ± 0.003 0.9798 ± 0.003
NBPscaled 0.7450 ± 0.03 0.8648 ± 0.019 0.8846 ± 0.028 0.9318 ± 0.025
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Table 5: AUC-ROC in the baySeq simulation setup for different true fold changes.
Fold change
Method 1.4 1.6 1.8 2
GNBP 0.8772 ± 0.009 0.9286 ± 0.005 0.9585 ± 0.004 0.9738 ± 0.001
BNBP 0.8823 ± 0.005 0.9382 ± 0.004 0.9674 ± 0.003 0.9812 ± 0.0015
edgeR 0.8702 ± 0.008 0.9216 ± 0.0042 0.9518 ± 0.004 0.9687 ± 0.003
DESeq 0.8705 ± 0.0083 0.9220 ± 0.004 0.9520 ± 0.0036 0.9688 ± 0.003
baySeq 0.7222 ± 0.0089 0.7887 ± 0.0067 0.8489 ± 0.012 0.8911 ± 0.0099
NBP 0.8769 ± 0.0075 0.9270 ± 0.0045 0.9567 ± 0.0031 0.9725 ± 0.0026
NBPscaled 0.8752 ± 0.009 0.9248 ± 0.0044 0.9571 ± 0.0071 0.9719 ± 0.0031
Table 6: AUC-PR in the baySeq simulation setup for different true fold changes.
Fold change
Method 1.4 1.6 1.8 2
GNBP 0.7194 ± 0.015 0.8372 0.0095 ± 0.8984 ± 0.0074 0.9332 ± 0.0041
BNBP 0.5733 ± 0.012 0.7448 ± 0.014 0.8826 ± 0.0055 0.9337 ± 0.0058
edgeR 0.7004 ± 0.013 0.8152 ± 0.008 0.8787 ± 0.0066 0.9173 ± 0.0054
DESeq 0.7042 ± 0.013 0.8180 ± 0.0082 0.8813 ± 0.0058 0.9194 ± 0.005
baySeq 0.5806 ± 0.0096 0.7034 ± 0.0057 0.7877 ± 0.0104 0.8482 ± 0.0106
NBP 0.7223 ± 0.0129 0.8312 ± 0.0075 0.8913 ± 0.0058 0.9248 ± 0.0055
NBPscaled 0.7203 ± 0.0155 0.8333 ± 0.006 0.8940 ± 0.012 0.9256 ± 0.0047
Table 7: Area under the ROC curve for the range with FPR ≤ 0.1 and area under the
PR curve for the range with Recall ≤ 0.1 for both the PSU and BGI datasets, with the
log2 cut-off value fixed at 2.
PSU BGI
Method AUCroc AUCpr AUCroc AUCpr
GNBP 0.0627 0.0980 0.0716 0.0995
BNBP 0.0628 0.0980 0.0685 0.0986
edgeR 0.0587 0.0980 0.0527 0.0995
DESeq 0.0514 0.0980 0.0521 0.0995
baySeq 0.0533 0.0980 0.0258 0.0757
NBP 0.0356 0.0921 0.0390 0.0968
NBPscaled 0.0404 0.0911 0.0369 0.0957
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(b) BNBP setup
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(c) baySeq setup
Figure 4: left column: ROC curve, right column: PR curve. Performance of different
methods in detecting the differential expression of simulated data generated from different
setups with a fold change of 1.8 for truly differentially expressed genes.
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Figure 5: Trace plots of 2000 MCMC samples for example parameters of the BNBP (left
column) and GNBP (right column) methods, applied to the BGI dataset.
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(a) Varying up/down-regulation proportions
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(b) Different sample sizes
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(c) Continuous true fold changes
Figure 6: left column: AUC-ROC values, right column: AUC-PR values. Performance
comparison of different methods in detecting differentially expressed genes under various sce-
narios using synthetic data generated with baySeq. (a) The proportion of up-regulated genes
in true differentially expressed genes increases from 20% to 80% with 20% increments. (b) The
sample size in each group is increased from 4 to 16 with increments of size 4. (c) The true fold
change of differentially expressed genes is sampled from a uniform distribution in the interval
[1.4, 2].
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(a) AUC-ROC
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Figure 7: (a) AUC-ROC and (b) AUC-PR in the baySeq simulation setup with 100 genes and
different sample sizes, where 10 genes are equally likely to be up- or down-regulated with a fold
change of 2.
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Figure 8: False discovery plots for different methods on the BGI dataset from the SEQC
project, with the log2 cut-off value fixed at 2. The x-axis shows the number of genes
selected, in order of their detected differential expression levels, while the y-axis shows
the number of selected genes that are false positives.
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